Pfizer (PFE) Enterprise Value (2009 - 2026)
Pfizer (PFE) reported Enterprise Value of -$12.8 billion for Q1 2026, up 24.95% year-over-year from -$10.2 billion in Q1 2025, and up 3.95% on a QoQ basis from -$13.3 billion in Q4 2025.
Pfizer (PFE) has 18 years of Enterprise Value data on file, last reported at -$12.8 billion in Q1 2026.
- Quarterly Enterprise Value rose 24.95% year-over-year to -$12.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.8 billion (up 24.95% YoY) and the FY2025 annual result came in at -$13.3 billion, up 34.12% from the prior year.
- Enterprise Value climbed to -$12.8 billion in Q1 2026 per PFE's latest filing, from -$13.3 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$6.8 billion in Q2 2024 and bottomed at -$44.5 billion in Q3 2023.
- The 5-year median for Enterprise Value is -$17.0 billion (2025), against an average of -$20.9 billion.
- The widest annual swing landed in 2024, when Enterprise Value soared 84.67%; it then plunged 89.48% in 2025.
- Tracing PFE's Enterprise Value over 5 years: stood at -$22.5 billion in 2022, then surged by 44.76% to -$12.4 billion in 2023, then plunged by 62.56% to -$20.2 billion in 2024, then jumped by 34.12% to -$13.3 billion in 2025, then advanced by 3.95% to -$12.8 billion in 2026.
- Per Business Quant, the three latest PFE Enterprise Value figures stand at -$12.8 billion (Q1 2026), -$13.3 billion (Q4 2025), and -$14.7 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -9.35 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -5.65 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -7.73 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -12.77 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -10.45 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | -4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -12.77 Bn |
| Dec 31, 2025 | -13.30 Bn |
| Sep 28, 2025 | -14.69 Bn |
| Jun 29, 2025 | -12.93 Bn |
| Mar 30, 2025 | -17.02 Bn |
| Dec 31, 2024 | -20.18 Bn |
| Sep 29, 2024 | -9.68 Bn |
| Jun 30, 2024 | -6.83 Bn |
| Mar 31, 2024 | -11.65 Bn |
| Dec 31, 2023 | -12.42 Bn |
| Oct 1, 2023 | -43.91 Bn |
| Jul 2, 2023 | -44.51 Bn |
| Apr 2, 2023 | -19.71 Bn |
| Dec 31, 2022 | -22.48 Bn |
| Oct 2, 2022 | -35.90 Bn |
| Jul 3, 2022 | -33.04 Bn |
| Apr 3, 2022 | -23.64 Bn |
| Dec 31, 2021 | -30.81 Bn |
| Oct 3, 2021 | -29.42 Bn |
| Jul 4, 2021 | -21.43 Bn |
| Apr 4, 2021 | -13.42 Bn |
| Dec 31, 2020 | -11.99 Bn |
| Sep 27, 2020 | -12.76 Bn |
| Jun 28, 2020 | -22.57 Bn |
| Mar 29, 2020 | -10.04 Bn |
| Dec 31, 2019 | -9.34 Bn |
| Sep 29, 2019 | -8.98 Bn |
| Jun 30, 2019 | -12.56 Bn |
| Mar 31, 2019 | -11.27 Bn |
| Dec 31, 2018 | -18.48 Bn |
| Sep 30, 2018 | -16.89 Bn |
| Jul 1, 2018 | -2.49 Bn |
| Apr 1, 2018 | -2.97 Bn |
| Dec 31, 2017 | -19.73 Bn |
| Oct 1, 2017 | -8.99 Bn |
| Jul 2, 2017 | -4.73 Bn |
| Apr 2, 2017 | -4.52 Bn |
| Dec 31, 2016 | -17.63 Bn |
| Oct 2, 2016 | -14.08 Bn |
| Jul 3, 2016 | -20.65 Bn |
| Apr 3, 2016 | -19.16 Bn |
| Dec 31, 2015 | -23.08 Bn |
| Sep 27, 2015 | -20.37 Bn |
| Jun 28, 2015 | -29.97 Bn |
| Mar 29, 2015 | -27.43 Bn |
| Dec 31, 2014 | -35.80 Bn |
| Sep 28, 2014 | -33.13 Bn |
| Jun 29, 2014 | -33.73 Bn |
| Mar 30, 2014 | -33.58 Bn |
| Dec 31, 2013 | -32.10 Bn |
| Sep 29, 2013 | -33.29 Bn |
| Jun 30, 2013 | -33.28 Bn |
| Mar 31, 2013 | -34.53 Bn |
| Dec 31, 2012 | -31.98 Bn |
| Sep 30, 2012 | -22.56 Bn |
| Jul 1, 2012 | -23.89 Bn |
| Apr 1, 2012 | -23.55 Bn |
| Dec 31, 2011 | -26.02 Bn |
| Oct 2, 2011 | -28.48 Bn |
| Jul 3, 2011 | -25.00 Bn |
| Apr 3, 2011 | -23.54 Bn |
| Dec 31, 2010 | -27.56 Bn |
| Oct 3, 2010 | -22.03 Bn |
| Jul 4, 2010 | -18.83 Bn |
| Apr 4, 2010 | -16.84 Bn |
| Dec 31, 2009 | -25.54 Bn |
| Sep 27, 2009 | -52.38 Bn |
| Jun 28, 2009 | -49.45 Bn |
| Mar 29, 2009 | -1.25 Bn |